Zoliflodacin for gonorrhea

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 2 registered trials.

Why this status

  1. 22 May 2019: Trial registered, NCT03959527
  2. 6 Nov 2019: Trial started, NCT03959527

The trials

NCT02257918: Randomized, Open-label Phase 2 Study of Oral AZD0914 in the Treatment of Gonorrhea

State
Completed
Phase
Phase 2
People
180 taking part
Started
25 Nov 2014
Primary completion
30 Dec 2015
Arms
Group 1, Group 2
Results
Posted on the registry
  1. 7 Oct 2014: Trial registered
  2. 30 Dec 2015: Trial completed
  3. 8 Feb 2017: Trial results posted

NCT03959527: Zoliflodacin in Uncomplicated Gonorrhoea

State
Completed
Phase
Phase 3
People
1,011 taking part
Started
6 Nov 2019
Primary completion
30 Aug 2023
Arms
zoliflodacin
Results
Posted on the registry
  1. 22 May 2019: Trial registered
  2. 6 Nov 2019: Trial started
  3. 18 Sep 2023: Trial completed
  4. 26 Jul 2024: Trial results posted

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

About the treatment

Kind of treatment: Drug.

Also known as Nuzolvence.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.